William Blair & Company
BNTX icon

William Blair & Company’s BioNTech BNTX Stock Holding History

William Blair & Company’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,973
Closed -$266K – 1826
2022
Q3 		$266K Sell
1,973
-57
-3% -$8.71K ﹤0.01% 1276
2022
Q2 		$303K Buy
2,030
+48
+2% +$7.33K ﹤0.01% 1263
2022
Q1 		$338K Sell
1,982
-84
-4% -$14.1K ﹤0.01% 1314
2021
Q4 		$533K Sell
2,066
-564
-21% -$154K ﹤0.01% 1188
2021
Q3 		$718K Hold
2,630
– – ﹤0.01% 1041
2021
Q2 		$589K Buy
2,630
+21
+0.8% +$3.96K ﹤0.01% 1092
2021
Q1 		$285K Buy
+2,609
New +$277K ﹤0.01% 1345

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

William Blair & Company's BNTX Position: Q4 2022 in Review

William Blair & Company sold out of BioNTech (BNTX) in Q4 2022, closing a stake of 1,973 shares — an estimated $266K sold.

William Blair & Company first reported a position in BNTX in Q1 2021 and held it in 7 quarters. The position peaked at $718K in Q3 2021. 320 funds tracked by Wall St. Rank hold BNTX as of Q4 2022.

  • William Blair & Company reported no remaining BioNTech position as of Q4 2022 after selling out during the quarter.
  • William Blair & Company sold 1,973 BioNTech shares in Q4 2022, an estimated $266K.
  • William Blair & Company first reported a position in BioNTech in Q1 2021 and held it in 7 quarters.
  • William Blair & Company's BioNTech position peaked at $718K in Q3 2021.
  • 320 funds tracked by Wall St. Rank held BioNTech as of Q4 2022.

Based on William Blair & Company's 13F filing for Q4 2022, filed 10 Feb 2023.